Providing strategic guidance towards a successful commercialization plan and improved valuation while staying focused on operational, regulatory, clinical, product development, financial and IP-related activities.
Engagement was provided with key investors for a number of MedTech start ups and early stage companies to support company funding requirements. These rounds included Seed, Series A and Series B. Amounts ranged from 2.5 Million USD to 50 Million USD.